Saturday, July 11, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 588
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

588 results for “placebo” Back to intelligence hub

Search results

Page 7 of 25
  1. Placebo

    AstraZeneca

    Irritable Bowel Syndrome With Constipation (IBS-C)

    phase 3 small molecule completed

    1 trial
  2. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 3 small molecule completed

    1 trial
  3. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Multiple Sclerosis

    phase 3 small molecule completed

    1 trial
  4. Placebo

    Milestone Pharmaceuticals

    Atrial Fibrillation

    phase 3 small molecule active

    1 trial
  5. Placebo

    Hoffmann-La Roche

    Schizophrenia

    phase 3 small molecule completed

    1 trial
  6. Placebo

    Biogen

    Multiple Sclerosis, Remittent Progressive

    phase 3 small molecule completed

    1 trial
  7. Placebo

    Regeneron UK Limited

    Gout

    phase 3 small molecule completed

    1 trial
  8. Placebo

    United Therapeutics Europe Ltd

    Gulf War Illness

    phase 3 small molecule active

    1 trial
  9. Placebo

    Madrigal Pharmaceuticals EU Limited

    Non-Alcoholic Fatty Liver Disease

    phase 3 small molecule completed

    1 trial
  10. Placebo

    Takeda

    Hypoparathyroidism

    phase 3 small molecule completed

    1 trial
  11. Placebo

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

    Schizoaffective Disorder

    phase 3 small molecule completed

    1 trial
  12. Placebo

    United Therapeutics Europe Ltd

    Idiopathic Pulmonary Fibrosis

    phase 3 small molecule completed

    1 trial
  13. Placebo

    SUPERNUS PHARMACEUTICALS, INC.

    Postpartum Depression

    phase 3 small molecule completed

    2 trials
  14. Placebo

    LEXICON PHARMACEUTICALS, INC.

    Type 1 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials
  15. Placebo

    Takeda

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial
  16. Placebo (for alirocumab)

    Regeneron UK Limited

    Hypercholesterolemia

    phase 3 small molecule completed

    5 trials
  17. Placebo (ziltivekimab), ziltivekimab

    NovoThirteen

    Acute myocardial infarction

    phase 3 small molecule active

    1 trial
  18. Placebo (ziltivekimab), ziltivekimab

    NovoThirteen

    Atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation

    phase 3 small molecule active

    1 trial
  19. Placebo Colchicine tablets for Aortic Valve Calcification, Inf…

    Disc Medicine

    Aortic Valve Calcification, Inflammation, Calcification, Aortic Valve Disease, Cardiovascular Diseases, Aortic Valve Stenosis

    phase 3 small molecule active

    1 trial
  20. Placebo Film-coated tablet, JNJ-42847922

    Janssen-Cilag International N.V.

    Major Depressive Disorder with Insomnia Symptoms

    phase 3 small molecule active

    1 trial
  21. Placebo MDPI

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    3 trials
  22. Placebo Matching Mitapivat

    Agios Netherlands B.V.

    Transfusion-dependent Alpha-Thalassemia

    phase 3 small molecule active

    1 trial
  23. Placebo Matching Mitapivat

    Agios Netherlands B.V.

    Non-Transfusion-dependent Alpha-Thalassemia

    phase 3 small molecule active

    1 trial
  24. Placebo Nasal Aerosol

    Teva Pharma GmbH

    Perennial Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.